AB Industrivärden (publ) (IDTVF)
USD 31.26
(0.0%)
USD 31.26
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.05 Billion | 5.23 Billion | 6.98 Billion | 491 Million | 3.87 Billion | 3.49 Billion |
| Net Income | 26.84 Billion | -13.96 Billion | 26.59 Billion | 8.44 Billion | 29.83 Billion | -8.33 Billion |
| Depreciation & Amortization | 5 Million | 5 Million | 5 Million | 5 Million | 6 Million | 1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -20.79 Billion | 19.19 Billion | -19.61 Billion | -7.95 Billion | -25.97 Billion | 11.82 Billion |
| Investing Cash Flow | -2.85 Billion | -3.18 Billion | -2.25 Billion | -4.1 Billion | 1.16 Billion | 3.25 Billion |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2.85 Billion | -3.18 Billion | -4.26 Billion | -4.31 Billion | - | - |
| Sales/Maturities of investments | - | - | 2 Billion | 205 Million | 1.16 Billion | 3.25 Billion |
| Other Investing Activities | -2.85 Billion | -3.18 Billion | 1 Million | -4.1 Billion | 1.16 Billion | 3.25 Billion |
| Financing Cash Flow | -3.12 Billion | -1.95 Billion | -4.03 Billion | 3.55 Billion | -5.76 Billion | -6.57 Billion |
| Debt repayment | -2 Million | -1.53 Billion | -3.05 Billion | -816 Million | -6.42 Billion | -4.04 Billion |
| Dividends payments | -3.13 Billion | -2.91 Billion | -3.59 Billion | - | -2.5 Billion | -2.39 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 4 Million | 2.49 Billion | 2.61 Billion | 4.37 Billion | 3.16 Billion | -134 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 795 Million | 697 Million | 6.98 Billion | 56 Million | 786 Million | 613 Million |
| Cash at end of period | 869 Million | 795 Million | 697 Million | -491 Million | 56 Million | 786 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -6.98 Billion | -491 Million | - | - |
| Net cash flow / Change in cash | 74 Million | 98 Million | -6.29 Billion | -547 Million | -730 Million | 173 Million |
| Free Cash Flow | 6.05 Billion | 5.23 Billion | 6.98 Billion | 491 Million | 3.87 Billion | 3.49 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -7.38 Billion | 16.52 Billion | 15.57 Billion | 26.84 Billion | -2.1 Billion |
| Depreciation & Amortization | - | - | - | 5 Million | 5 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | - | 12.27 Billion | -13.13 Billion | -15.56 Billion | -20.79 Billion | 2.03 Billion |
| Investing Cash Flow | -1.62 Billion | -1.23 Billion | -887 Million | -805 Million | -2.85 Billion | -951 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.62 Billion | -1.23 Billion | -887 Million | -805 Million | -2.85 Billion | -951 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.23 Billion | -887 Million | -805 Million | -2.85 Billion | -951 Million |
| Financing Cash Flow | 2 Million | -4.24 Billion | -8 Million | -2 Million | -3.12 Billion | 2 Million |
| Debt repayment | -2 Million | -898 Million | -999 Million | -2 Million | -2 Million | -2 Million |
| Dividends payments | - | -3.34 Billion | - | - | -3.13 Billion | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -991 Million | - | - | 4 Million | 4 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 2.71 Billion | 3.35 Billion | 4.25 Billion | 1.66 Billion | 795 Million | 2.61 Billion |
| Cash at end of period | 1.08 Billion | 2.76 Billion | 3.35 Billion | 869 Million | 869 Million | 1.66 Billion |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -3.38 Billion | - | - | 78 Million |
| Net cash flow / Change in cash | -1.62 Billion | -590 Million | -895 Million | -797 Million | 74 Million | -949 Million |
| Free Cash Flow | - | 4.89 Billion | 3.38 Billion | 10 Million | 6.05 Billion | -78 Million |
ASCO
RAMAPHO
601018
BTI
CSS
9879